| Name | Title | Contact Details |
|---|
Financial Technology Partners is a San Francisco, CA-based company in the Financial Services sector.
Texada Capital Corporation is a Grasonville, MD-based company in the Financial Services sector.
Casimir Capital is a New York, NY-based company in the Financial Services sector.
Foresite Capital is an uncommon mix of investment analysts, MD/PhDs and data scientists who believe that solving the world`s biggest healthcare problems requires a radically collaborative approach, free of arbitrary silos and competition. That`s why we created an atypical investment firm that funds companies at every part of their lifecycle, from early-stage through public liquidity and beyond, because value creation doesn`t stop at the IPO. It takes a village to build tomorrow`s great healthcare franchise, so with Foresite, our companies get all of our experts and networks at their fingertips, each dedicated to their success over many years. Foresite Capital seeks extraordinary teams, not just visionary founders, that understand that success is realized by grinding away at hard problems over the long haul, with Foresite Capital at-the-ready to help navigate the complex healthcare landscape. Headquartered in San Francisco with offices in New York and Marin County, Foresite Capital is led by CEO Jim Tananbaum.
RA Capital Management (“RA Capital”) is a multi-stage investment manager dedicated to evidence-based investing in public and private healthcare and life science companies that are developing drugs, medical devices, and diagnostics. The flexibility of its strategy allows RA Capital to lead private, IPO, and follow-on financings for its portfolio companies, both facilitating the crossover process and allowing management teams to drive value creation with minimal capital concerns from inception through commercialization. RA Capital`s scientifically trained research team is intensely data driven in its continual effort to identify early breakthroughs and originate conviction in new ideas. The team`s understanding of industry best practices is derived from an extensive collection of case studies documenting the impact of clinical trial design, partnership structures, public market dynamics, and many other factors on valuation and business viability.